Viewpoint: Lessons learned from 2009 H1N1 Influenza-so far
An editorial that examines the current status of H1N1 in the medical setting.
In some cases the children are asymptomatic, but parents want them evaluated anyway. Some come seeking vaccination, but some are fearful about what they perceive as a new, untested vaccine that might harm their child.
Many children are, indeed, suffering from influenza. If this were any other flu season, their parents might be comfortable treating the fever, cough, and aches with antipyretics and fluids, but this year they are afraid.
Here are some things we've learned:
Perhaps this wave of H1N1 influenza A will have passed by the time you read this-just in time to deal with our usual winter viral respiratory season.
DR. MCMILLAN, editor-in-chief of Contemporary Pediatrics, is professor of pediatrics, vice chair for pediatric education, and director of the pediatric residency training program, Johns Hopkins University School of Medicine, Baltimore.
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
